The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identifying an early indicator of drug efficacy in patients (pts) with metastatic colorectal cancer (mCRC): A prospective evaluation of circulating tumor cells (CTC), 18F-fluorodeoxyglucose positron-emission tomography (PET), and the RECIST criteria.
Brigette Ma
No relevant relationships to disclose
Ann Dorothy King
No relevant relationships to disclose
LI Leung
No relevant relationships to disclose
Annette Poon
No relevant relationships to disclose
Ki Wang
No relevant relationships to disclose
Herbert H. F. Loong
No relevant relationships to disclose
Rosalie Ho
No relevant relationships to disclose
Frankie Mo
No relevant relationships to disclose
Wing Ming Ho
No relevant relationships to disclose
Charles Chan
No relevant relationships to disclose
Anthony T. C. Chan
No relevant relationships to disclose
Cesar SC Wong
No relevant relationships to disclose